Who are Mistral Therapeutics's investors?

Mistral Therapeutics's investors include Versant Ventures.

How much funding has Mistral Therapeutics raised?

Mistral Therapeutics has disclosed $36.4M raised across 2 rounds.

Mistral Therapeutics is headquartered in San Diego, US.

San Diego, US · Founded 2011 · Delaware corporation · 1 known investors

Your email: who you already know at Mistral Therapeutics, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Mistral Therapeutics team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Petpiboon PrasitNamed on SEC filing

THOMAS A COLLNamed on SEC filing

Jeremy Caldwell Board directorVenture Partner at Versant Ventures

Clare Ozawa Board directorManaging Director at Versant Ventures

Jerel Davis Board directorManaging Director at Versant Ventures

Bradley BolzonBoard directorChairman, Managing Director at Versant Ventures

Form D private placements

$36.4M disclosed across 2 rounds · 2011–2018

▶$25.9MraisedJun 2018 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

▶$10.5MraisedJun 2014 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Who are Mistral Therapeutics's investors?: Mistral Therapeutics's investors include Versant Ventures.
How much funding has Mistral Therapeutics raised?: Mistral Therapeutics has disclosed $36.4M raised across 2 rounds.
Where is Mistral Therapeutics headquartered?: Mistral Therapeutics is headquartered in San Diego, US.